For the year ending 2025-12-31, DH had $56,864K increase in cash & cash equivalents over the period. $37,057K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Revenue | 241,521 |
| Total cost of revenue | 58,246 |
| Sales and marketing | 81,637 |
| Product development | 34,776 |
| General and administrative | 51,627 |
| Other segment items, net | -224,491 |
| Benefit from income taxes | -9,959 |
| Net loss | -199,297 |
| Depreciation and amortization | 3,303 |
| Amortization of intangible assets | 52,807 |
| Amortization of deferred contract costs | 15,871 |
| Equity-based compensation | 29,144 |
| Amortization of debt issuance costs | 519 |
| Write-off of deferred offering costs | 467 |
| (recovery of) provision for bad debt expense | -232 |
| Loss on partial extinguishment of debt | -507 |
| Non-cash restructuring charges | 595 |
| Goodwill impairment charges | 196,064 |
| Tra remeasurement | 21,706 |
| Changes in fair value of contingent consideration | -3,970 |
| Deferred income taxes | 10,878 |
| Accounts receivable | -1,384 |
| Prepaid expenses and other assets | 2,249 |
| Deferred contract costs | -13,352 |
| Contingent consideration | 0 |
| Accounts payable, accrued expenses and other liabilities | -1,088 |
| Deferred revenue | 5,888 |
| Net cash provided by operating activities | 53,777 |
| Purchases of property, equipment and other assets | 16,720 |
| Purchases of short-term investments | 64,065 |
| Maturities of short-term investments | -234,660 |
| Cash paid for acquisitions and investments, net of cash acquired | 0 |
| Net cash provided by (used in) investing activities | 153,875 |
| Repayments of term loans | 252,813 |
| Proceeds from term loan | 175,000 |
| Payments of debt issuance costs | 1,660 |
| Taxes paid related to net share settlement of equity awards | 4,948 |
| Repurchases of class a common stock | 49,452 |
| Payments of contingent consideration | 0 |
| Payments under tra | 13,767 |
| Payments of equity offering issuance costs | 0 |
| Member distributions | 3,148 |
| Net cash used in financing activities | -150,788 |
| Net increase (decrease) in cash and cash equivalents | 56,864 |
Definitive Healthcare Corp. (DH)
Definitive Healthcare Corp. (DH)